InvestorQ : How do you see the Lupin stock after its Mar-20 results?
shrinidhi Rajan made post

How do you see the Lupin stock after its Mar-20 results?

Answer
user profile image
Riya Dwivedi answered.
5 months ago


For the Mar-20 quarter, Lupin reported 35% jump in net profit at Rs.390 crore on account of a one-time gain accrued from the divestment of its stake in Kyowa Pharma of Japan. However, Lupin’s operational performance was hit by a fall in sales in the US and APAC markets. While the profit from the Kyowa Pharma sale was substantially recorded in the Dec-19 quarter, some Rs.121 crore was booked in this quarter. Total sales in the Indian market rose 13.3% to Rs.1192 crore, North American market fell by 9.3% to Rs.1579 crore. Overall, sales for the quarter were down marginally at Rs.3791 crore. Due to weak sales performance, the company reported a 300 bps fall in OPM to 19.4%. In a nutshell, Lupin had strong momentum in its two major markets of the US and India. Most of the FDA related compliance issues have also been resolved.